Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209775%3A_____%2F10%3A%230000004" target="_blank" >RIV/00209775:_____/10:#0000004 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/10:00046815 RIV/00216208:11150/10:10070545 RIV/00179906:_____/10:10070545
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy
Original language description
A case of patient with hyper-IgE syndrome and diffuse large B-cell lymphoma who achieved a durable remission after modified immunochemotherapy is rported. Heterozygous point mutation (c.1259A > C) in codon 340 of the DNA-binding domain of STAT3 was detected in the patient .
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2010
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Leukemia Research
ISSN
0145-2126
e-ISSN
—
Volume of the periodical
34
Issue of the periodical within the volume
9
Country of publishing house
GB - UNITED KINGDOM
Number of pages
3
Pages from-to
—
UT code for WoS article
000280576500029
EID of the result in the Scopus database
—